Profile: BioTechnology General(Israel) Ltd. offers Bio-Hep-B®, which is a novel recombinant vaccine. Our vaccine is produced by the expression of pre-S1, pre-S2 and S protein components of HBsAg in hamster ovary cells. The process yields particles that resemble circulating 22-nm particles in protein composition & glycosylation pattern and harbor all antigenic epitopes & domains of the Hbv envelope.